Day One Biopharmaceuticals's total assets for Q2 2025 were $519.04M, a decrease of -2.87% from the previous quarter. DAWN total liabilities were $58.20M for the fiscal quarter, a 6.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.